Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials.
Journal: Arquivos de neuro-psiquiatria
Published: February 07, 2024
Time course of the autoantibody response to therapy in anti-MAG neuropathy: TWO case REPORTS.
Journal: Heliyon
Published: January 21, 2024
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.
Journal: Journal of the peripheral nervous system : JPNS
Published: April 14, 2023
Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.
Journal: Expert review of neurotherapeutics
Published: January 16, 2023
Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139.
Journal: Microorganisms
Published: December 27, 2022
Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy.
Journal: Microorganisms
Published: October 02, 2022
Immune mechanisms, the role of complement, and related therapies in autoimmune neuropathies.
Journal: Expert review of clinical immunology
Published: November 09, 2021
Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years.
Journal: Current opinion in neurology
Published: July 16, 2021
Relapsing Bickerstaff Brainstem Encephalitis After Autologous Stem Cell Transplant.
Journal: Journal of clinical neuromuscular disease
Published: May 27, 2020
FGFR3 autoantibodies in sensory neuronopathy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 06, 2019
Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
Journal: The Lancet. Neurology
Published: January 19, 2018
Measuring disease activity and clinical response during maintenance therapy in CIDP: from ICE trial outcome measures to future clinical biomarkers.
Journal: Neurodegenerative disease management
Published: January 24, 2017
Last Updated: 09/26/2026